Buyang Huanwu Decoction Attenuates Infiltration of Natural Killer Cells and Protects Against Ischemic Brain Injury

被引：55

作者：

Dou, Baokai ^{[1
,2
,3
]}

Zhou, Wenjin ^{[1
]}

Li, Shichun ^{[1
]}

Wang, Lixin ^{[1
]}

Wu, Ximin ^{[2
]}

Li, Yiming ^{[2
]}

Guan, Huida ^{[3
]}

Wang, Changhong ^{[3
]}

Zhu, Shiguo ^{[1
]}

Ke, Zunji ^{[1
]}

Huang, Cheng ^{[2
]}

Wang, Zhifei ^{[1
]}

机构：

[1] Shanghai Univ Tradit Chinese Med, Sch Basic Med Sci, 1200 Cailun Rd, Shanghai, Peoples R China

[2] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China

[3] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China

来源：

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY | 2018年 / 50卷 / 04期

基金：

中国国家自然科学基金;

关键词：

Buyang Huanwu Decoction; Cerebral ischemia; Natural killer cells; Nuclear factor-kappa B; CXCL10; CXCR3; INTERFERON-INDUCIBLE PROTEIN-10; MIDDLE CEREBRAL-ARTERY; RAT MODEL; STROKE; EXPRESSION; MECHANISMS; RECRUITMENT; OCCLUSION; SYSTEM; ROLES;

D O I：

10.1159/000494587

中图分类号：

Q2 [细胞生物学];

学科分类号：

071013 [干细胞生物学];

摘要：

Background/Aims: Natural killer (NK) cells are among the first immune cells that respond to an ischemic insult in human brains. The infiltrated NK cells damage blood-brain barrier (BBB) and exacerbate brain infarction. Buyang Huanwu Decoction (BHD), a classic Chinese traditional herbal prescription, has long been used for the treatment of ischemic stroke. The present study investigated whether BHD can prevent brain infiltration of NK cells, attenuate BBB disruption and improve ischemic outcomes. Methods: Transient focal cerebral ischemia was induced in rats by a 60-minute middle cerebral artery occlusion, and BHD was orally administrated at the onset of reperfusion, 12 hours later, then twice daily. Assessed parameters on Day 3 after ischemia were: neurological and motor functional deficits through neurological deficit score and rotarod test, respectively; brain infarction through TTC staining; BBB integrity through Evans blue extravasation; matrix metalloproteinase-2/9 activities through gelatin zymography; tight junction protein, nuclear factor-kappa B (NF-kappa B) p65 and phospho-p65 levels through Western blotting; NK cell brain infiltration and CXCR3 levels on NK cells through flow cytometry; interferon-gamma production through ELISA; CXCL10 mRNA levels through real-time PCR; CXCL10 expression and p65 nuclear translocation through immunofluorescence staining. Results: BHD markedly reduced brain infarction, improved rotarod performance, and attenuated BBB breakdown. Concurrently, BHD attenuated the upregulation of matrix metalloproteinase-2/9 activities and the degradation of tight junction proteins in the ischemic brain. Infiltration of NK cells was observed in the ischemic hemisphere, and this infiltration was blunted by treatment with BHD. BHD suppressed brain ischemia-induced interferon-gamma and chemokine CXCL10 production. Furthermore, BHD significantly reduced the expression of CXCR3 on brain-infiltrated NK cells. Strikingly, BHD did not affect NK cell levels or its CXCR3 expression in the spleen or peripheral blood after brain ischemia. The nuclear translocation of NF-kappa B p65 and phospho-p65 in the ischemic brain was inhibited by BHD. Conclusion: Our findings suggest that BHD prevents brain infiltration of NK cells, preserves BBB integrity and eventually improves ischemic outcomes. The inhibitory effects of BHD on NK cell brain invasion may involve its ability of suppressing NF-kappa B-associated CXCL10-CXCR3-mediated chemotaxis. Notably, BHD only suppresses NK cells and their CXCR3 expression in the ischemic brain, but not those in periphery. (C) 2018 The Author(s) Published by S. Karger AG, Basel

引用

页码：1286 / 1300

页数：15

共 35 条

[1]

Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone [J].